Stock 600557 JIANGSU KANION PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Jiangsu Kanion Pharmaceutical Co.,Ltd.

Equities

600557

CNE000001CL7

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
18.36 CNY -2.08% Intraday chart for Jiangsu Kanion Pharmaceutical Co.,Ltd. -7.51% -10.53%
Apr. 25 Jiangsu Kanion Pharmaceutical Co.,Ltd. Equity Buyback Plan Extended till February 5, 2025. CI
Apr. 12 Jiangsu Kanion Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Jiangsu Kanion Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The Company's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The Company distributes its products mainly within domestic markets.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Injection
44.7 %
1,451 33.4 % 2,174 44.7 % +49.80%
Capsules
18.2 %
873 20.1 % 888 18.2 % +1.70%
Oral Liquid
17.8 %
1,122 25.8 % 864 17.8 % -22.99%
Tablets and Pills
7.2 %
338 7.8 % 351 7.2 % +3.68%
Granules and Granules
6.7 %
281 6.5 % 328 6.7 % +16.82%
Patch
4.3 %
226 5.2 % 211 4.3 % -6.55%
Other
0.6 %
27 0.6 % 28 0.6 % +2.98%
Gel
0.5 %
32 0.7 % 24 0.5 % -26.07%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
4,351 100.0 % 4,868 100.0 % +11.88%

Managers

Managers TitleAgeSince
Yong Chun Yang CEO
 Chief Executive Officer 51 96-12-31
Suo Cheng Jiang DFI
 Director of Finance/CFO 47 00-11-30
Wei Xiao CHM
 Chairman 65 00-11-30
Mei Ling Jiang BRD
 Director/Board Member 44 05-12-31
Di Wu BRD
 Director/Board Member 42 11-12-31
Xue Bin Chen BRD
 Director/Board Member 39 21-12-31
Hai Xin Gao BRD
 Director/Board Member 36 13-12-31
Lin Jiang BRD
 Director/Board Member 42 20-12-31
Zhen Zhong Wang BRD
 Director/Board Member 56 92-12-31
Yan Xi Chen IRC
 Investor Relations Contact 37 09-06-30

Members of the board

Members of the board TitleAgeSince
Wei Xiao CHM
 Chairman 65 00-11-30
Kai Xian Chen BRD
 Director/Board Member 78 19-12-26
Yong Chun Yang CEO
 Chief Executive Officer 51 96-12-31
Zhen Zhong Wang BRD
 Director/Board Member 56 92-12-31
Shi Hua Yin CHM
 Chairman 49 17-09-30
Chang Qin Hu BRD
 Director/Board Member 49 92-12-31
Hai Xin Gao BRD
 Director/Board Member 36 13-12-31
Xue Bin Chen BRD
 Director/Board Member 39 21-12-31
Jin Ao Duan BRD
 Director/Board Member 68 23-06-25
Di Wu BRD
 Director/Board Member 42 11-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 588,898,052 337,095,106 ( 57.24 %) 7,100,600 ( 1.206 %) 57.24 %

Shareholders

NameEquities%Valuation
Jiangsu Kanion Group Co., Ltd.
30.56 %
176,173,467 30.56 % 477 M ¥
Lianyungang Kangbeier Medical Equipment Co. Ltd.
5.529 %
31,870,567 5.529 % 86 M ¥
China Investment Corp. (Investment Management)
3.103 %
17,886,480 3.103 % 48 M ¥
Wei Xiao
2.950 %
17,003,232 2.950 % 46 M ¥
China Asset Management Co., Ltd.
2.150 %
12,392,263 2.150 % 34 M ¥
Shanghai Silver Leaf Investment Co., Ltd.
2.072 %
11,945,196 2.072 % 32 M ¥
CHINA MERCHANTS BANK CO., LTD.
1.489 %
8,580,753 1.489 % 23 M ¥
China Southern Asset Management Co., Ltd.
1.388 %
7,998,043 1.388 % 22 M ¥
Essence Fund Co., Ltd.
1.314 %
7,574,253 1.314 % 21 M ¥
Rongtong Fund Management Co., Ltd.
1.031 %
5,940,600 1.031 % 16 M ¥
NameEquities%Valuation
Zhen Zhong Wang
2.571 %
210,000 2.571 % 568 970 ¥
Yong Chun Yang
2.571 %
210,000 2.571 % 568 970 ¥
Chuan Lei Wang
1.714 %
140,000 1.714 % 379 313 ¥
Yu Pan
1.714 %
140,000 1.714 % 379 313 ¥
Quan Liu
1.714 %
140,000 1.714 % 379 313 ¥
Hai Xin Gao
1.714 %
140,000 1.714 % 379 313 ¥
Yun Wu
1.285 %
105,000 1.285 % 284 485 ¥
Dian Hong Xu
0.7345 %
60,000 0.7345 % 162 563 ¥

Company contact information

Jiangsu Kanion Pharmaceutical Co., Ltd.

58 Kangyuan Road Jiangning Industrial town

222000, Lianyungang

+86 518 8552 1948

http://www.kanion.com
address Jiangsu Kanion Pharmaceutical Co.,Ltd.(600557)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Jiangsu Kanion Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
18.36 CNY
Average target price
25.17 CNY
Spread / Average Target
+37.11%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JIANGSU KANION PHARMACEUTICAL CO.,LTD. Stock Jiangsu Kanion Pharmaceutical Co.,Ltd.
-10.53% 1.47B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.36% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.15% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.02% 369B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.57% 332B
ABBVIE INC. Stock AbbVie Inc.
+2.58% 282B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.34% 244B
NOVARTIS AG Stock Novartis AG
+9.64% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-4.58% 205B
PFIZER, INC. Stock Pfizer, Inc.
+0.40% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600557 Stock
  4. Company Jiangsu Kanion Pharmaceutical Co.,Ltd.